Last Funding Date: 2023-01-06
Investors Number: 13.0
Industry: Early Drug Development
Last Funding Type: Post-IPO Equity
Headquarters: Rockville, Maryland, United States
Total Funding: 169606744.0
Funding Status: IPO
Employee Number: 101-250
Estimated Revenue: $1M to $10M
Founded Date: 2002-01-01